Open to all conference attendees. 

In a marketplace defined by rising drug costs, shrinking margins, and mounting plan sponsor frustration, this panel brings together leaders from across the PBM landscape for a rare, unscripted conversation. With transparency mandates accelerating and traditional revenue models eroding, PBMs are being asked to evolve, and fast. This session will explore the shifting economics of pharmacy benefit management, the realities of PBM margins, rural pharmacy access, regulatory pressure, and the future of PBM contracting, where employers are no longer passive purchasers but active architects of their benefit strategy.
This session invites attendees to temporarily set aside animus and lean into understanding. These panelists, representing diverse PBM models of consequence aren’t here to defend the past. They’re here to provide insights specific to how we got here, and how we move forward. From clinical program innovation to lowest net cost strategies, we’ll challenge legacy thinking and explore whether a true performance ethos can replace the architypes of the past. Come prepared to ask tough questions, hear honest answers, and leave with a clearer view of how employers and PBMs might finally move in tandem toward sustainable and aligned outcomes.